PGC-1α participates in tumor chemoresistance by regulating glucose metabolism and mitochondrial function

Mol Cell Biochem. 2023 Jan;478(1):47-57. doi: 10.1007/s11010-022-04477-2. Epub 2022 Jun 17.

Abstract

Chemotherapy resistance is the main reason for the failure of cancer treatment. The mechanism of drug resistance is complex and diverse. In recent years, the role of glucose metabolism and mitochondrial function in cancer resistance has gathered considerable interest. The increase in metabolic plasticity of cancer cells' mitochondria and adaptive changes to the mitochondrial function are some of the mechanisms through which cancer cells resist chemotherapy. As a key molecule regulating the mitochondrial function and glucose metabolism, PGC-1α plays an indispensable role in cancer progression. However, the role of PGC-1α in chemotherapy resistance remains controversial. Here, we discuss the role of PGC-1α in glucose metabolism and mitochondrial function and present a comprehensive overview of PGC-1α in chemotherapy resistance.

Keywords: Cancer; Chemoresistance; Metabolism; Mitochondrion; PGC-1α.

Publication types

  • Review

MeSH terms

  • Drug Resistance, Neoplasm*
  • Glucose / metabolism
  • Humans
  • Mitochondria / metabolism
  • Neoplasms* / drug therapy
  • Neoplasms* / metabolism
  • Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha / metabolism

Substances

  • Glucose
  • Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
  • PPARGC1A protein, human